Search

Your search keyword '"Alzheimer's disease -- Statistics"' showing total 201 results

Search Constraints

Start Over You searched for: Descriptor "Alzheimer's disease -- Statistics" Remove constraint Descriptor: "Alzheimer's disease -- Statistics"
201 results on '"Alzheimer's disease -- Statistics"'

Search Results

1. Weight loss jabs cut sudden death threat and fight 40 conditions. Drugs reduce the chances of cardiac arrest by more than 20 per cent and can even stave off Alzheimer's

3. New laser-based test 'could detect different types of dementia in seconds'; Initial tests have shown it can identify Alzheimer's disease with an average accuracy of more than 93 per cent

5. New Alzheimer Disease Findings from Department of Statistics Described (Impacts of informant replacement in two industry-sponsored Alzheimer's disease clinical trials)

6. New Multi-Marker Blood Test from Lucent Diagnostics Increases the Number of Patients Receiving Early Alzheimer's Disease Diagnostic Information

7. New Multi-Marker Blood Test from Lucent Diagnostics Increases the Number of Patients Receiving Early Alzheimer's Disease Diagnostic Information

8. IGC Pharma reports Phase 2 data highlighting cognitive gains with IGC-AD1 for Alzheimer's treatment

9. IGC Pharma reports Phase 2 data highlighting cognitive gains with IGC-AD1 for Alzheimer's treatment

10. Recent Research from University of California San Diego (UCSD) Highlight Findings in Alzheimer Disease (Self- and Study Partner-reported Cognitive Decline In Older Adults Without Dementia: the Role of A-synuclein and Amyloid Biomarkers In the ...)

11. Lucrative Incentive for Biotechs as Global Alzheimer's Disease Therapeutics Market Forecasted to Reach $30.8 Billion By 2033

13. AARP Bulletin's March Issue: Unlocking the Secrets of a Stress-Free Tax Season, Grocery Store Deceits That Cost You, and the Hot Job Market (for Dogs)

14. Songs aim to hit right note on Alzheimer’s; Widow of Nobel physics laureate Charles Kao joins collaboration to raise public knowledge of degenerative brain disease through original numbers

15. New Disease Biomarkers Findings from National Institute on Aging Described (Association of plasma Alzheimer's and neurodegenerative disease biomarkers with brain volume loss and cognitive decline)

16. ALZHEIMER'S BY THE NUMBERS

17. Missouri Alzheimer's numbers increasing significantly

18. Researchers at Nathan S. Kline Institute for Psychiatric Research Release New Data on Down Syndrome [Lysosomal Dysfunction In Down Syndrome and Alzheimer Mouse Models Is Caused By V-atpase Inhibition By Tyr(682)-phosphorylated App Beta Ctf]

19. Global Neuromodulation Devices Markets, 2022-2029: Growing Prevalence of Central Nervous System Disorders Such as Parkinson Disease, Alzheimer Disease, Multiple Sclerosis, Epilepsy Bolsters Growth

22. Findings in the Area of Down Syndrome Reported from Nathan S. Kline Institute for Psychiatric Research (Profiling Basal Forebrain Cholinergic Neurons Reveals a Molecular Basis for Vulnerability Within the Ts65dn Model of Down Syndrome and ...)

23. Alzheimer's Therapeutics market is projected to grow at a CAGR of 9.17% by 2032: Visiongain Reports Ltd

25. Alzheimer's Therapeutics market is projected to grow at a CAGR of 9.17% by 2032: Visiongain Reports Ltd

26. Three Lions hitmaker David Baddiel on football's role in the fight against dementia; The comedian whose 'national anthem' went to No.1 in the charts will be at England v Switzerland, a football match designated as an Alzheimer's Society international, remembering his late father and Astle's closing numbers

27. Advocates are stressing need for more paid Alzheimer's caregivers: Shortage likely to worsen as number of patients on rise

28. Investigators at Leibniz Institute for Primate Research Have Reported New Data on Iron-Binding Proteins (Increased oxidative stress, hyperphosphorylation of tau, and dystrophic microglia in the hippocampus of aged Tupaia belangeri)

29. Investigators from University of Colorado Anschutz Medical Campus Release New Data on Alzheimer Disease (Increased Kif11/kinesin-5 Expression Offsets Alzheimer a Beta-mediated Toxicity and Cognitive Dysfunction)

31. New Findings from Sapienza University of Rome Yields New Data on Down Syndrome (Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: Focus on HNE-modified proteins in a mouse model of down syndrome)

32. AHA News: Statistics Report Offers Snapshot of the Nation's Brain Health - And a Guide to Protecting It

33. Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging

34. Deaths from dementia and Alzheimers at home up 79 per cent in pandemic; Heart disease and cancer deaths at home have also risen significantly

35. New Alzheimer Disease Findings Reported from University of Melbourne (Increased Glutaminyl Cyclase Activity In Brains of Alzheimer's Disease Individuals)

36. HIGHER RATES OF ALZHEIMER'S DEATHS, HOSPITALIZATIONS CORRELATE WITH AIR POLLUTION

37. Centenarians who avoid dementia

38. Global CNS Therapeutics Industry (2020 to 2025) - Increased Spending on Prescription Drugs Bodes Well for the Market - ResearchAndMarkets.com

39. Global CNS Therapeutics Industry (2020 to 2025) - Increased Spending on Prescription Drugs Bodes Well for the Market

40. NYS Institute for Basic Research in Developmental Disabilities Researchers Report Recent Findings in Down Syndrome (Developmental deficits and staging of dynamics of age associated Alzheimer's disease neurodegeneration and neuronal loss in ...)

41. Researchers at University of Fukui Publish New Data on Alzheimer Disease (Clioquinol Decreases Levels of Phosphorylated, Truncated, and Oligomerized Tau Protein)

42. New Medical Statistics Data Have Been Reported by Investigators at Banner Alzheimer's Institute (Limitations of Clinical Trial Sample Size Estimate By Subtraction of Two Measurements)

43. The hit parade: medical/surgical journals have seen better days but there is a silver lining in the sector that has been hit hard the past few years. Anthony Vecchione reports on some of the industry's bright spots

46. NIH forecasts approximately 6 million American with Alzheimer's disease, cognitive impairment

47. U.S. Alzheimer's 2017 spending may reach $259 billion

49. Top 20 pharma companies: while the US saw a rebound in prescription drug growth in 2006, few companies are sitting pretty. Matthew Arnold charts the trends, events, stories and numbers of the biggest players

50. Number of patients with dementia rises, services lag behind

Catalog

Books, media, physical & digital resources